Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 1;12(4):611-615.
doi: 10.21037/hbsn-23-308. Epub 2023 Jul 11.

Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition

Stefano Ciardullo  1   2 , Michela Vergani  1   2 , Celeste Ronchetti  1   2 , Gianluca Perseghin  1   2
Affiliations
Editorial

Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition

Stefano Ciardullo et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Nonalcoholic fatty liver disease (NAFLD); definition; fatty liver; metabolic-associated fatty liver disease (MAFLD); pediatrics.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-308/coif). GP reports receiving honorarium from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Echosens, Lily, Menarini Diag, MSD, Novartis, Novo Nordisk, Pfizer, PikDare, Roche Diag, Sanofi and Servier and he is on the scientific advisory board of Intercept, Lily, Merck, Novartis, Novo Nordisk, Pfizer, PikDare, Sanofi. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388-93. 10.1542/peds.2006-1212 - DOI - PubMed
    1. Ciardullo S, Monti T, Perseghin G. Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017-2018 National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 2021;19:384-90.e1. 10.1016/j.cgh.2020.06.048 - DOI - PubMed
    1. Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017;64:319-34. 10.1097/MPG.0000000000001482 - DOI - PMC - PubMed
    1. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020;73:202-9. 10.1016/j.jhep.2020.03.039 - DOI - PubMed
    1. Eslam M, Alkhouri N, Vajro P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol 2021;6:864-73. 10.1016/S2468-1253(21)00183-7 - DOI - PubMed